Remdesivir Treatment Had to Stop in 4 of 5 Patients Due to Side Effects

Some of the first results from clinical trials with Remdesivir, the drug being promoted as the answer to SARS-CoV-2 treatment, have been released and, so far, it doesn’t look so good. Four of the five trial participants had adverse side effects, including renal failure with two patients requiring transplants. In related news, members of the COVID-19 Treatment Guidelines Panel, which makes recommendations on treatments for the virus, had to disclose any financial conflicts they may...

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports